English
Polski
Español
українська
Screening for malignancy in patients with unprovoked VTE
Is it rational to perform screening tests for malignancy in patients with unprovoked VTE?
2020-10-02
Is it rational to perform screening tests for malignancy in patients with unprovoked VTE?
A 23-year-old woman with an ovarian cyst treated with oral contraceptives develops lower limb edema. A diagnosis of deep vein thrombosis (DVT) is established solely on the basis of the D-dimer level. The patient receives LMWH and is sent home. After a few hours she develops pulmonary embolism (PE).
How long should anticoagulant treatment be used as venous thromboembolism (VTE) prophylaxis in hospitalized patients? Should it be continued after discharge?
What is the current role of mechanical venous thromboembolism (VTE) prophylaxis?
Who should receive venous thromboembolism (VTE) prophylaxis before a long-haul flight? What form of prophylaxis should be used?
What should be the diagnostic workup in a patient with suspected deep vein thrombosis (DVT)?
What deep vein thrombosis (DVT) prophylaxis should be used in an older bedridden patient in a long-term care facility? What do you think about heparin or compression stockings in such settings?
Is there still a place for unfractionated heparin and low-molecular-weight heparin (LMWH) in the current management of venous thromboembolism (VTE)? When to use them?
What is the best approach to antiplatelet treatment in patients on long-term anticoagulation?
What antithrombotic prophylaxis should be used in acutely ill hospitalized medical patients? Should it be used in such patients who remain at home or in long-term care institutions?
